LIF anticorps (Center)
Aperçu rapide pour LIF anticorps (Center) (ABIN2299943)
Antigène
Voir toutes LIF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 79-109, Center
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Leukemia Inhibitory Factor (LIF, Cholinergic Differentiation Factor, CDF, DIA, Differentiation-stimulating Factor, D Factor, HILDA, Melanoma-derived LPL Inhibitor, MLPLI)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to a corresponding to a portion of amino acids within aa79-109 from the center region of human LIF, conjugated to KLH.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Autre désignation
- Leukemia Inhibitory Factor
-
NCBI Accession
- NP_002300
-
UniProt
- P15018
-
Pathways
- Signalistation JAK/STAT, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Antigène
-